Research Article

Characteristics of Clinical Shiga Toxin-Producing Escherichia coli Isolated from British Columbia

Table 2

Antimicrobial resistance, serotypes, PFGE, plasmid, and virulence profiles of clinical STEC isolated from British Columbia.

Strain no. SerotypeVirulence genesXbaI PFGE profile Plasmid profile (kb) AMR phenotype
(subtype) (subtype)

BC-13O8:H16++ +ECXA1.2261100, 16, 12, 8, 7 BCNI, NEOI, SPTI, STRI
BC-14O26:H11+++ECXA1.251393, 14, 7 NEO, TETI
BC-5O26:H11+++ECXA1.251593, 80, 14, 7, 6, 3.5, 2.5 NEOI
BC-10O26:H11+++ECXA1.228093, 14, 7 NEOI, SPTI
BC-4O26:NM+++ECXA1.251693, 14, 7 NEOI, SPTI
BC-11O73:H2+ ++NDb100 BCNI, SPTI, STR, TETI, NEOI
BC-3O103:H3+++ECXA1.2517100, 93, 14, 7, 5 BCN, NEO, SPTI, TET
BC-12O103:H25+++ECXA1.226293 STR, NEOI
BC-7O111:NM+++ND93, 80, 65, 14, 7, 6, 3.5 NEOI
BC-6O118:H16+++ND93, 14, 7, 6 BCNI, KANI, NEO, SPT, STR, TET
BC-2O121:H19+ +ECXA1.2518None NEOI, SPTI
BC-1O121:UT+ ++ECXA1.251893 NEO, SPTI
BC-15O146:H21+ +ND80, 15, 12, 8 NEOI
BC-8O165:NM++ +ECXA1.251493 AMPI, NEOI, SPT, TETI
BC-9O165:NM++ +ECXA1.251493 NEOI, TETI
BC-16O157:H7+ ++ECXA1.002393 NEO
BC-17O157:H7++ ++ECXA1.242693 SPTI
BC-18O157:H7++ ++ECXA1.220393, 80, 65 CHL, NEOI, SPTI, STR, TET
BC-19O157:H7++ ++ECXA1.000193, 70 TETI
BC-20O157:H7++ ++ECXA1.241293, 70, 3.5 AMC, AMP, FOX, CAZ, TIO, STRI
BC-21O157:H7++ ++ECXA1.241293, 80, 65 CHL, NEOI, STR, TET
BC-22O157:H7+ ++ECXA1.220393, 80, 50, 30 NEOI
BC-23O157:H7++ ++ECXA1.085493 NEOI, SPTI
BC-24O157:H7++ ++ECXA1.110793 NEO, SPTI
BC-25O157:H7++ ++ECXA1.239793 NEOI, SPTI

All were subtype with a single exception; bnot determined; Idenotes reduced susceptibility.